Correlation Between Connect Biopharma and Artelo Biosciences
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Artelo Biosciences, you can compare the effects of market volatilities on Connect Biopharma and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Artelo Biosciences.
Diversification Opportunities for Connect Biopharma and Artelo Biosciences
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Connect and Artelo is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Artelo Biosciences go up and down completely randomly.
Pair Corralation between Connect Biopharma and Artelo Biosciences
Given the investment horizon of 90 days Connect Biopharma Holdings is expected to generate 0.98 times more return on investment than Artelo Biosciences. However, Connect Biopharma Holdings is 1.02 times less risky than Artelo Biosciences. It trades about -0.03 of its potential returns per unit of risk. Artelo Biosciences is currently generating about -0.04 per unit of risk. If you would invest 129.00 in Connect Biopharma Holdings on September 3, 2024 and sell it today you would lose (21.00) from holding Connect Biopharma Holdings or give up 16.28% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Connect Biopharma Holdings vs. Artelo Biosciences
Performance |
Timeline |
Connect Biopharma |
Artelo Biosciences |
Connect Biopharma and Artelo Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Connect Biopharma and Artelo Biosciences
The main advantage of trading using opposite Connect Biopharma and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.Connect Biopharma vs. DiaMedica Therapeutics | Connect Biopharma vs. Lyra Therapeutics | Connect Biopharma vs. Centessa Pharmaceuticals PLC |
Artelo Biosciences vs. Aileron Therapeutics | Artelo Biosciences vs. Histogen | Artelo Biosciences vs. Curis Inc | Artelo Biosciences vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |